Amgen Inc. urged a federal judge to overturn a jury’s $50.3 million verdict for its leukemia drug Blincyto’s infringement of ...

How Has the Blincyto Market Grown in Recent Years? The Blincyto market has experienced significant growth over the past few years. Key insights indicate: .The market is projected to increase from ...

Associate Professor Shaun Fleming said the listing of Blincyto meant patients could avoid the potentially fatal side effects of chemotherapy. “Typically, patients with ALL are being treated with ...

In my opinion, thanks in part to Blincyto, Enbrel, Imdelltra, Tezspire, and Amjevita/Amgevita, Amgen is getting closer to the leaders in these markets, namely AstraZeneca (AZN) and Johnson ...